HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ezlopitant

structure in first source
Also Known As:
(2S,3S,4S)-2-diphenylmethyl-3-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane; 1-Azabicyclo(2.2.2)octan-3-amine, 2-(diphenylmethyl)-N- ((2-methoxy-5-(1-methylethyl)phenyl)methyl)-, (2S-cis)-; 2-diphenylmethyl-3-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane; (2S,3S)-2-(Diphenylmethyl)-3-((5-isopropyl-2-methoxy- benzyl)amino)quinuclidine
Networked: 4 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fujiwara, Yoshiko: 1 article (11/2002)
2. Kanai, Yoshihito: 1 article (11/2002)
3. Mizutani, Mayumi: 1 article (11/2002)
4. Nagahisa, Atsushi: 1 article (11/2002)
5. Shimada, Kaoru: 1 article (11/2002)
6. Suga, Osamu: 1 article (11/2002)
7. Tsuchiya, Megumi: 1 article (11/2002)
8. Ueda, Satoko: 1 article (11/2002)
9. Watson, John W: 1 article (11/2002)
10. Callahan, Michael J: 1 article (07/2002)

Related Diseases

1. Vomiting
2. Pain (Aches)
3. Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
4. Dehydration (Water Stress)

Related Drugs and Biologics

1. Cisplatin (Platino)
2. Cytochrome P-450 CYP3A
3. Benzyl Alcohol (Benzenemethanol)
4. Cytochrome P-450 CYP2D6 (CYP2D6)
5. Tachykinins
6. Isotopes
7. Deuterium
8. Antiemetics
9. Alkenes (Olefins)

Related Therapies and Procedures

1. Subcutaneous Injections
2. Intraperitoneal Injections